| P50 | author | Karly Garnock-Jones | Q38543892 |
| P2860 | cites work | Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology: | Q22242896 |
| | Pharmacology of ASL-8052, a Novel β-Adrenergic Receptor Antagonist with an Ultrashort Duration of Action | Q51853180 |
| | Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. | Q54116167 |
| | 2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation | Q56986288 |
| | Usefulness of esmolol in unstable angina pectoris. European Esmolol Study Group | Q68301891 |
| | Esmolol and ventilatory function in cardiac patients with COPD | Q68321680 |
| | Clinical pharmacology, pharmacodynamics and interactions with esmolol | Q69870965 |
| | Effects of esmolol on cardiac function: evaluation by noninvasive techniques | Q69870971 |
| | Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade | Q69871267 |
| | Comparison of the efficacy and safety of esmolol, a short-acting beta blocker, with placebo in the treatment of supraventricular tachyarrhythmias. The Esmolol vs Placebo Multicenter Study Group | Q69876883 |
| | Metabolism and urinary excretion of esmolol in humans | Q69877434 |
| | Effects of esmolol on airway function in patients with asthma | Q69878974 |
| | Hemodynamic effects of esmolol, an ultrashort-acting beta blocker | Q69906547 |
| | Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: a multicenter double-blind clinical trial | Q69916325 |
| | Kinetics of esmolol, an ultra-short-acting beta blocker, and of its major metabolite | Q71033416 |
| | Antiarrhythmic activity of esmolol (ASL-8052)--a novel ultra-short acting beta-adrenoreceptor blocking agent | Q72572963 |
| | Perioperative hypertension management | Q24644852 |
| | Efficacy of esmolol versus alfentanil as a supplement to propofol-nitrous oxide anesthesia | Q28323070 |
| | Assessment of the efficacy of esmolol on the haemodynamic changes induced by laryngoscopy and tracheal intubation: a meta-analysis | Q31012179 |
| | The use of esmolol as an alternative to remifentanil during desflurane anesthesia for fast-track outpatient gynecologic laparoscopic surgery | Q31834598 |
| | Management of Atrial Fibrillation: Translating Clinical Trial Data into Clinical Practice | Q33713422 |
| | ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary. a report of the American college of cardiology/American heart association task force on practice guidelines and the European society of cardi | Q34542591 |
| | 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). | Q34636529 |
| | Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial | Q34778589 |
| | Hypertension and anesthesia. | Q36493041 |
| | Meta-analysis of the effect of heart rate achieved by perioperative beta-adrenergic blockade on cardiovascular outcomes | Q37009425 |
| | Perioperative beta blockers in patients having non-cardiac surgery: a meta-analysis | Q37326885 |
| | Common types of supraventricular tachycardia: diagnosis and management | Q37800473 |
| | The safety of perioperative esmolol: a systematic review and meta-analysis of randomized controlled trials | Q37815353 |
| | RETRACTED: Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients | Q38382733 |
| | Esmolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy | Q39463135 |
| | Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia | Q39537717 |
| | Esmolol. A review of its therapeutic efficacy and pharmacokinetic characteristics | Q40530277 |
| | Esmolol reduces perioperative ischemia in noncardiac surgery: a meta-analysis of randomized controlled studies. | Q43267649 |
| | Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery | Q43284567 |
| | The effect of an infusion of esmolol on the incidence of myocardial ischaemia during tracheal extubation following coronary artery surgery | Q43817697 |
| | Randomized study of early intravenous esmolol versus oral beta-blockers in preventing post-CABG atrial fibrillation in high risk patients identified by signal-averaged ECG: results of a pilot study | Q44017687 |
| | Esmolol in acute ischemic syndromes | Q44209419 |
| | Esmolol prevents movement and attenuates the BIS response to orotracheal intubation | Q44230995 |
| | Pharmacokinetics of esmolol in hepatic disease | Q44800259 |
| | Labetalol and esmolol in the control of hypertension after intracranial surgery | Q44857262 |
| | Role of beta-blockade in anaesthesia and postoperative pain management after hysterectomy | Q45065546 |
| | The effect of esmolol on the QTc interval during induction of anaesthesia in patients with coronary artery disease | Q46080464 |
| | Esmolol reduces perioperative ischemia in cardiac surgery: a meta-analysis of randomized controlled studies | Q46083293 |
| | Beta-1 selective adrenergic antagonist landiolol and esmolol can be safely used in patients with airway hyperreactivity. | Q46159062 |
| | A randomised study of perioperative esmolol infusion for haemodynamic stability during major vascular surgery; rationale and design of DECREASE-XIII. | Q46184279 |
| | Use of an ultra short-acting beta-blocker in patients with acute myocardial ischemia | Q46200415 |
| | Acute beta-adrenoceptor blockade improves efficacy of ibutilide in conversion of atrial fibrillation with a rapid ventricular rate. | Q46262350 |
| | Pharmacokinetics of esmolol and ASL-8123 in renal failure | Q46387971 |
| | The safety, efficacy, and pharmacokinetics of esmolol for blood pressure control immediately after repair of coarctation of the aorta in infants and children: a multicenter, double-blind, randomized trial | Q46436409 |
| | The electrocardiographic and hemodynamic effect of metohexital and propofol with and without esmolol | Q46906840 |
| | Intraoperative esmolol infusion in the absence of opioids spares postoperative fentanyl in patients undergoing ambulatory laparoscopic cholecystectomy | Q46932679 |
| | Esmolol reduces anesthetic requirement for skin incision during propofol/nitrous oxide/morphine anesthesia. | Q51549250 |
| | QT interval of the ECG, heart rate and arterial pressure during anaesthetic induction: comparative effects of alfentanil and esmolol. | Q51598732 |
| | Modification of the haemodynamic responses to induction of anaesthesia and tracheal intubation with alfentanil, esmolol and their combination. | Q51606623 |
| | Pharmacokinetics of esmolol in anesthetized patients receiving chronic beta blocker therapy. | Q51794437 |
| P433 | issue | 1 | |
| P921 | main subject | arterial hypertension | Q41861 |
| | tachycardia | Q209583 |
| P304 | page(s) | 109-132 | |
| P577 | publication date | 2012-01-01 | |
| P1433 | published in | Drugs | Q3040094 |
| P1476 | title | Esmolol: a review of its use in the short-term treatment of tachyarrhythmias and the short-term control of tachycardia and hypertension | |
| P478 | volume | 72 | |